US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
イギリス
LSE
Resverlogix Corp (0VF9) 銘柄情報

Resverlogix Corp (0VF9)

1.68

0.00

(0.00%)

終了 7月11日 12:30AM

Resverlogix Corp (0VF9) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

1.68

( - )

買値

1.68

売値

1.68

出来高

0.00

平均取引量 (3 か月)

$ 31,966

財務取引量

-

0.00 日の範囲 0.00

1.68 52 週間の範囲 1.68

時価総額

企業価値

112.497M

前日終値

1.68

始値

-

時刻

最終取引時間

VWAP

-

歳入

-

純利益

-6.22M

発行済株式数

343,841,709

浮動株比率 (%)

72.93%

機関投資家保有比率 (%)

-

配当利回り

PER

-3.28

株価売上高倍率 (PSR)

-

1 株当たり利益 (EPS)

-0.02

ベータ

1.05

Resverlogix Corp., a late-stage clinical biotechnology company, develops therapeutics for patients with chronic illnesses. Its lead drug is apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor for patients with cardiovascular disease, chronic kidney disease, typ... Resverlogix Corp., a late-stage clinical biotechnology company, develops therapeutics for patients with chronic illnesses. Its lead drug is apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor for patients with cardiovascular disease, chronic kidney disease, type 2 diabetes mellitus, low high-density lipoprotein, recent acute coronary syndrome, and post COVID-19 conditions. The company has a partnership with Eversana Life Science Services, LLC to support the commercialization of apabetalone for COVID-19 in the United States and Canada; developing cardiovascular and pulmonary arterial hypertension indications; and Medison Pharma Ltd. The company is headquartered in Calgary, Canada. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.resverlogix.com

本社

Calgary, Canada

設立

-

Resverlogix Corp is listed in the sector of the ロンドン証券取引所 with ticker 0VF9. The last closing price for Resverlogix was $1.68. Over the last year, Resverlogix shares have traded in a share price range of $ 1.68 to $ 1.68.

Resverlogix currently has 343,841,709 shares in issue. The market capitalisation of Resverlogix is $577.65 million. Resverlogix has a price to earnings ratio (PE ratio) of -3.28.

Resverlogix Announces Commencement of Patient Enrollment and Dosing in a Phase 2b Trial for a Promising Canadian-Developed COVID-19 Treatment

Resverlogix Announces Commencement of Patient Enrollment and Dosing in a Phase 2b Trial for a Promising Canadian-Developed COVID-19 Treatment...

Resverlogix Enters into a Cooperation Agreement with the Supreme Council of the Arab-African Economy to Support the Development of Apabetalone for COVID-19 Patients

Resverlogix Enters into a Cooperation Agreement with the Supreme Council of the Arab-African Economy to Support the Development of Apabetalone...

Resverlogix In Active Discussions With The Kingdom of Morocco’s Ministry of Health For The Launch Of COVID-19 Clinical Studies With First-In-Class Drug Apabetalone

Resverlogix In Active Discussions With The Kingdom of Morocco’s Ministry of Health For The Launch Of COVID-19 Clinical Studies With...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	1.68	1.68	1.68	1772	1.68	DE
52	0	0	1.68	1.68	1.68	3290	1.68	DE
156	0	0	1.68	1.68	1.68	3046	1.68	DE
260	0	0	1.68	1.68	1.68	1905	1.68	DE

0VF9 - Frequently Asked Questions (FAQ)

What is the current Resverlogix Corp share price?

The current share price of Resverlogix Corp is $ 1.68

How many Resverlogix Corp shares are in issue?

Resverlogix Corp has 343,841,709 shares in issue

What is the market cap of Resverlogix Corp?

The market capitalisation of Resverlogix Corp is CAD 577.65M

What is the 1 year trading range for Resverlogix Corp share price?

Resverlogix Corp has traded in the range of $ 1.68 to $ 1.68 during the past year

What is the PE ratio of Resverlogix Corp?

The price to earnings ratio of Resverlogix Corp is -3.28

What is the registered address of Resverlogix Corp?

The registered address for Resverlogix Corp is 4820 Richard Road SW, Calgary, Alberta, T3E 6L1

What is the Resverlogix Corp website address?

The website address for Resverlogix Corp is www.resverlogix.com

Sleepy$$$

Sleepy$$$ 30分前

Added a few k yesterday and bidding. Funny this one gets no attention. .07 - $15

Paul Brentjens

Paul Brentjens 36分前

yes, got that message too, yesterday morning.
Temporary error I guess, on CS..
Works again

WooptdooU

WooptdooU 38分前

Lwlg's No risk, Grifter, current leader has a greatest fear and the shorts seems to know the situation.
Whi would replace yves? Seems there are several who can spin the same wheels.

Teddytropics

Teddytropics 43分前

Thanks for showing yourself..

For new eyes, the linked material being presented as relevant is 4 years old from the Old CEO.

Currently he has nothing to do with the company and there has been zero evidence presented by;

The Pro-Bas

Mr79

https://media4.giphy.com/media/v1.Y2lkPTZjMDliOTUydTl4Ynh6azU1ZjkxeDd3YXgyb2FkOHF6ZXdqZHd3dHdueGJranM1NCZlcD12MV9pbnRlcm5hbF9naWZfYnlfaWQmY3Q9Zw/hwvbZ1kHDPdAs/giphy.gifhttps://media0.giphy.com/media/v1.Y2lkPTZjMDliOTUycTk4c3EzaWFoMm4xZTZjbXFieGFybGphZng0cW9uODZoeDZka2d4diZlcD12MV9pbnRlcm5hbF9naWZfYn

Nytoncva

Nytoncva 59分前

He may have already raised a chunk this past week, obviously not 9M, but anyone know what volume the first day was? Yesterday was less than average at only 700k. That really felt like dilution on day 1. Even with the poor PR, in this market environment I really would have expected more strength. I

Squirrely_McShitty

Squirrely_McShitty 1時間前

I assume you're talking smack to lower the price.

Yes, 432m shares outstanding with 600m authorized is simply horrible for an OTC company, lol. Claude Solitario is a bum too, aye?

Claude Solitario, for those who don't know, co-founded Invatec Health, a private company,

Nemesis18

Nemesis18 1時間前

If all was well, NWBO wouldn't have needed to do the latest 'data drag net' presentation. It smacks of a last desperate hail mary pass to satisfy both the MHRA and NICE forensic statisticians.

Nemesis18

Nemesis18 2時間前

>>Yep... all those people who had GBM and are alive 8, 10, 12 years later really agree with your opinion.... clown!!! 🙄

eagle8

eagle8 2時間前

Not that i know.

GLTU

DTGoody

DTGoody 2時間前

They're going to reverse merge with a Medical Courier Driver from PA to Deliver Anti-Depressants to the ENCC Shareholders who sold their shares right before a massive reverse merger happened! LOL :))

chereb19

chereb19 2時間前

This post is a good reminder that confidence and accuracy aren't the same thing. You predicted the FDA wouldn't "give the green light." The FDA subsequently approved the IDE to begin the human feasibility study. It's perfectly reasonable to remain skeptical, but it's also reasonable to acknowledge w

Wallstreeter$$$

Wallstreeter$$$ 2時間前

Typical lazy DD Norman cuz u wouldve seen I later said I would hold a core position in Vivos longer term. Btw numbnuts I've been swing trading this from day one, sometimes taking small profits but reinvesting most of it in new stock. Heck i've been increasing my position without spending one red cen

searay2701

searay2701 2時間前

I suggest that folks check BRC Laboratory com. A test has been completed on Insultex but it shows no completion date, could this one with no date on it be from an earlier testing than the one we are currently waiting for?

PickStocks

PickStocks 3時間前

Bill becomes law?

north40000

north40000 3時間前

“Cost-saving legislation in healthcare passed by German parliament didn’t help matters either.

murrayhill

murrayhill 3時間前

O'Jays - Backstabber
https://www.youtube.com/watch?v=RmXRQ3vfzcA

flipper44

flipper44 3時間前

Hi Baxers, I just don’t buy that a proposed refusal occurred followed by an appeal.

Perhaps this is one of those rare moments opposite forces align to try and make NWBO spill the beans.

Regardless, the way the system works, according to MHRA, is that CTBVEAG does not ma

janice shell

janice shell 3時間前

You know all the fuss that's being made about the tacky "Freedom Fuel" gas stations that have popped up in Southeast Pennsylvania and part of New Jersey...

All over the news for several days now. It's a mystery!! Who owns them? Some Trump buddy? Very likely, but oddly enough, nobody

shajandr

shajandr 3時間前

Dave:

Prison - you're nott gonna like big boy prison.

https://investorshub.advfn.com/uimage/uploads/2026/7/11/exmlgbeaumont.jpg
https://investorshub.advfn.com/uimage/uploads/2014/3/21/m[igcinmateArrival.jpg
https://investorshub.advfn.com/uimage/uploads/202

chereb19

chereb19 4時間前

Every time you're wrong, you don't revisit your thesis—you just invent a new one. First it was "they'll never get an IDE." Then it became "it's only an EFS IDE." Now it's dilution, patents and OTC. The conclusion never changes; only the excuse does.

You're throwing everything at the w

International bond 0.5% ...

1.62% 08feb2044 1.62% 08...

It Now ISE Fundo De Indice

Anglo American (QX)

Tenaya Therapeutics

BridgeBio Oncology Thera...

4.75% 13mar2028

DJSP Enterprises (EM)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。